Nephrology

Stopping RAS inhibitors after an eGFR decline may increase risk of kidney failure and death, according to a large cohort study.

Novel urinary biomarkers could improve CKD risk stratification by capturing tubular injury and repair beyond traditional albuminuria measures.

A new study identifies key predictors of successful renal replacement therapy weaning and introduces a bedside tool to guide ICU decision-making.

Greater chronic kidney disease severity, particularly proteinuria, is linked to increased risk of cognitive impairment, a large cohort study finds.

RAAS inhibitors reduce kidney failure risk and improve blood pressure control compared with calcium channel blockers in children with CKD, new real-world data show.

Interim results from the Phase III VISIONARY trial show that sibeprenlimab significantly reduced proteinuria and improved disease biomarkers in patients with IgA nephropathy.

A large UK study finds commonly used eGFR equations may overestimate kidney function, potentially delaying chronic kidney disease diagnosis and treatment.

A study suggests convection volume in haemodiafiltration may be tailored to patient weight and residual kidney function to optimise middle-molecule clearance.